Intrahepatic cholestasis of pregnancy

Angela K. Grone, James Smith, Jr.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Intrahepatic cholestasis of pregnancy is characterized by pruritus, elevated bile acids and liver enzymes, and occasionally jaundice. It has specific implications for maternal and perinatal outcomes. Symptomatic and therapeutic treatment with ursodeoxycholic acid is usually initiated. Bile acid levels in their initial and serial determination can assist with antepartum management. Preterm delivery, meconium-stained amniotic fluid, and respiratory distress commonly complicate these pregnancies. The difficulty in predicting and preventing unanticipated fetal death near term drives the obstetrician's desire to deliver infants before 38 weeks. The neonatologist in turn manages potential complications related to prematurity and the compounding negative effect of bile acids on respiratory function. The pathophysiology of elevated maternal bile acid levels on the fetal lung should prompt a high level of care and attention during the first hours after birth in all newborn infants born to women with intrahepatic cholestasis of pregnancy.

Original languageEnglish
JournalNeoReviews
Volume13
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Bile Acids and Salts
Mothers
Ursodeoxycholic Acid
Meconium
Fetal Death
Amniotic Fluid
Pruritus
Jaundice
Parturition
Newborn Infant
Pregnancy
Lung
Intrahepatic Cholestasis of Pregnancy
Liver
Enzymes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Intrahepatic cholestasis of pregnancy. / Grone, Angela K.; Smith, Jr., James.

In: NeoReviews, Vol. 13, No. 3, 03.2012.

Research output: Contribution to journalArticle

Grone, Angela K. ; Smith, Jr., James. / Intrahepatic cholestasis of pregnancy. In: NeoReviews. 2012 ; Vol. 13, No. 3.
@article{9f1c85894eb44f2f8e03dee4efe5640b,
title = "Intrahepatic cholestasis of pregnancy",
abstract = "Intrahepatic cholestasis of pregnancy is characterized by pruritus, elevated bile acids and liver enzymes, and occasionally jaundice. It has specific implications for maternal and perinatal outcomes. Symptomatic and therapeutic treatment with ursodeoxycholic acid is usually initiated. Bile acid levels in their initial and serial determination can assist with antepartum management. Preterm delivery, meconium-stained amniotic fluid, and respiratory distress commonly complicate these pregnancies. The difficulty in predicting and preventing unanticipated fetal death near term drives the obstetrician's desire to deliver infants before 38 weeks. The neonatologist in turn manages potential complications related to prematurity and the compounding negative effect of bile acids on respiratory function. The pathophysiology of elevated maternal bile acid levels on the fetal lung should prompt a high level of care and attention during the first hours after birth in all newborn infants born to women with intrahepatic cholestasis of pregnancy.",
author = "Grone, {Angela K.} and {Smith, Jr.}, James",
year = "2012",
month = "3",
doi = "10.1542/neo.13-3-e145",
language = "English",
volume = "13",
journal = "NeoReviews",
issn = "1526-9906",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Intrahepatic cholestasis of pregnancy

AU - Grone, Angela K.

AU - Smith, Jr., James

PY - 2012/3

Y1 - 2012/3

N2 - Intrahepatic cholestasis of pregnancy is characterized by pruritus, elevated bile acids and liver enzymes, and occasionally jaundice. It has specific implications for maternal and perinatal outcomes. Symptomatic and therapeutic treatment with ursodeoxycholic acid is usually initiated. Bile acid levels in their initial and serial determination can assist with antepartum management. Preterm delivery, meconium-stained amniotic fluid, and respiratory distress commonly complicate these pregnancies. The difficulty in predicting and preventing unanticipated fetal death near term drives the obstetrician's desire to deliver infants before 38 weeks. The neonatologist in turn manages potential complications related to prematurity and the compounding negative effect of bile acids on respiratory function. The pathophysiology of elevated maternal bile acid levels on the fetal lung should prompt a high level of care and attention during the first hours after birth in all newborn infants born to women with intrahepatic cholestasis of pregnancy.

AB - Intrahepatic cholestasis of pregnancy is characterized by pruritus, elevated bile acids and liver enzymes, and occasionally jaundice. It has specific implications for maternal and perinatal outcomes. Symptomatic and therapeutic treatment with ursodeoxycholic acid is usually initiated. Bile acid levels in their initial and serial determination can assist with antepartum management. Preterm delivery, meconium-stained amniotic fluid, and respiratory distress commonly complicate these pregnancies. The difficulty in predicting and preventing unanticipated fetal death near term drives the obstetrician's desire to deliver infants before 38 weeks. The neonatologist in turn manages potential complications related to prematurity and the compounding negative effect of bile acids on respiratory function. The pathophysiology of elevated maternal bile acid levels on the fetal lung should prompt a high level of care and attention during the first hours after birth in all newborn infants born to women with intrahepatic cholestasis of pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=84861404221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861404221&partnerID=8YFLogxK

U2 - 10.1542/neo.13-3-e145

DO - 10.1542/neo.13-3-e145

M3 - Article

AN - SCOPUS:84861404221

VL - 13

JO - NeoReviews

JF - NeoReviews

SN - 1526-9906

IS - 3

ER -